APCI is pleased to announce the hiring of Greg Reybold as Director of Healthcare Policy and General Counsel effective September 1, 2021. In his new position, Mr. Reybold will work with the APCI legislative team to develop healthcare policy at both the state and federal levels as well as manage the co-op’s legal strategy.
Mr. Reybold is a veteran healthcare attorney, government affairs professional, and litigator with an expertise in combating abusive pharmacy benefit manager (PBM) practices through legislative and regulatory processes. Prior to joining APCI, Mr. Reybold served as General Counsel and Vice President of Public Policy for the Georgia Pharmacy Association (GPhA).
“Greg Reybold has a strong history of developing legislation to monitor and regulate PBMs, and getting that legislation enacted into law,” said Tim Hamrick, APCI Chief Executive Officer. “He has done a fantastic job for patients and community pharmacy during his time with the Georgia Pharmacy Association, and we are proud and extremely fortunate to have Greg join the APCI team. We look forward to continuing the work he started in Georgia and expand PBM regulation in state legislatures across the country and in Congress.”
“I couldn’t be more excited to be joining the APCI team and taking up the fight to fix a broken prescription drug system,” Mr. Reybold said. “There is no organization in the country that is more committed, passionate, or better positioned to break the current cycle of opaque and abusive PBM practices than APCI. I am ready to roll up my sleeves and work with Bill Eley and the rest of the team toward solutions that end the cycle of PBM abuse and bring a fair and transparent system that works for pharmacies, payors, and patients.”
“Greg Reybold has one of the best legal and regulatory minds in the entire prescription drug supply chain,” said Antonio Ciaccia, President of consulting firm 3 Axis Advisors, who is known throughout the industry for his work on drug pricing. “His wisdom, expertise, and relentless drive for correcting a broken drug distribution system make him a perfect asset to APCI and the pharmacy community at large. He’s the right guy at the right time and will be perfectly positioned to drive further disruption in the industry on day one and beyond.”
During his time at the helm of GPhA’s government affairs’ team, Mr. Reybold worked with the Georgia General Assembly to pass the Association’s legislative priorities every year of his seven year tenure. Highlights of his work include drafting the nation’s first Pharmacy Patient Protection Act in 2017, the nation’s first PBM/pharmacy affiliate anti-steering legislation in 2019, and the nation’s first PBM surcharge in 2020. In addition, Mr. Reybold orchestrated opposition to the CVS/Aetna merger which resulted in Georgia specific patient and provider protections. Much of this legislation has been the basis for enacted legislation throughout the country as well as model legislation.
“We wish Greg all the best,” said Bob Coleman, CEO of the Georgia Pharmacy Association. “He’s been an integral part of GPhA’s legislative successes over the past years and we look forward to continuing to work with him in his new role with APCI in the future. This isn’t goodbye, it’s more like aloha.”
Mr. Reybold is also a recognized expert and speaker on PBM issues and has consulted and advised several state and national organizations on PBM legislation, and has been a featured speaker at conferences and on podcasts.
Prior to joining GPhA, Mr. Reybold was a partner in the law firm Daley Koster, LLC. In private practice, Mr. Reybold maintained a governmental practice and healthcare practice with a strong emphasis on independent pharmacy. Mr. Reybold is a graduate of Emory University School of Law.